Interní Med. 2017; 19(4): 220-222

Co nového o apixabanu přinesl kongres ESC 2017?

prof. MUDr. Petr Neužil, CSc., FESC
Nemocnice Na Homolce, Praha

Received: October 30, 2018; Accepted: November 12, 2018; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neužil P. Co nového o apixabanu přinesl kongres ESC 2017? Interní Med. 2017;19(4):220-222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Soška V. Terapie DLP. In: Poruchy metabolismu lipidů. Diagnostika a léčba. Grada, 2001; 82-86.
    2. Janský P, Rosolová H, Vrablík M. 2016 ESC/EAS Guidelines for the management of Dyslipidaemias. Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa 2017; 59: 389-415. Go to original source...
    3. Češka R. Praktické postupy v léčbě HLD a DLP. In: Cholesterol a ateroskleróza, léčba dyslipidemií. Triton 2012; 337-353.
    4. Soška V, Vaverková H, Vrablík M, et al. Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011. Doporučené postupy. Vnitř Lék 2013; 59(2): 120-126. Go to PubMed...
    5. Rosolová H. Současný stav hypolipidemické léčby u nás. Interv Akut Kardiol 2016; 15(2): 81-84. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.